In the First Quarter of 2024, Telefield Medical Imaging Limited closed the transaction. The company amended the terms of the transaction. The company has received HKD 19,571,525 ($2.5 million) in its second and final tranche, led by new investor AEF Greater Bay Area Venture Fund, a fund managed by Gobi Partners, closing and received a total of HKD 59,571,525 ($60 million).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.78 CNY | +0.25% | -1.61% | -4.99% |
May. 15 | Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment | MT |
May. 15 | China Approves Clinical Trials For Breast Cancer Drugs | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.99% | 7.94B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Telefield Medical Imaging Limited announced that it has received HKD 59.571525 million in funding Gobi Partners